FDA — authorised 28 June 2018
- Application: NDA210361
- Marketing authorisation holder: JOURNEY
- Local brand name: QBREXZA
- Indication: CLOTH — TOPICAL
- Status: approved
FDA authorised Glycopyrronium 2.4 % Medicated Cloth on 28 June 2018
Yes. FDA authorised it on 28 June 2018.
JOURNEY holds the US marketing authorisation.